A.I.Sure Pharmaceutical Private Limited
A.I.Sure Pharmaceutical Private Limited is a Private Non-govt company company incorporated in 2018 and based in PN, India. A.I.Sure Pharmaceutical Private Limited operates in Personal Services (NIC 93090) with authorized capital of ₹27.00 L and paid-up capital of ₹26.67 L. For 2022-23, the company reported revenue of ₹40.82 L and a net loss of ₹21.70 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Quick facts
Directors
LockedDirectors, DINs & appointment history for A.I.Sure Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +11d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for A.I.Sure Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 866050895 | Kotak Mahindra Bank Ltd(Bank) | ₹2.56 Cr | 27 Jan 2021 | Open |
| 619006370 | Axis Bank Ltd(Bank) | ₹13.73 Cr | 19 Sep 2021 | Satisfied |
| 212330096 | HDFC Bank Ltd(Bank) | ₹24.49 Cr | 27 Jan 2020 | Open |
| 179631629 | State Bank of India(Bank) | ₹1.38 Cr | 19 Sep 2022 | Satisfied |
| 893013722 | ICICI Bank Ltd(Bank) | ₹12.25 Cr | 19 Sep 2020 | Open |
Charge IDs, lenders & amounts for A.I.Sure Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2022-23 | — | ||||
| 2021-22 | — |
Detailed Financials
2 FYs| Line item | 2022-23 | 2021-22 |
|---|---|---|
| Income statement | ||
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Total expenses | ||
| Profit before tax | ||
| Profit / (Loss) after tax | ||
| Balance sheet | ||
| Equity / Net worth | ||
| Borrowings | ||
| Current liabilities | ||
| Total liabilities | ||
| Current assets | ||
| Cash & equivalents | ||
| Total assets | ||
| Employees | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2022-23 | +3.0% | — | — | |
| Profit after Tax2022-23 | — | — | — | |
| Net Worth2022-23 | — | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-22 | -89.75% | — | — | -30.45% | — | |||
| 2022-23 | -53.16% | +7.85% | — | -26.38% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 63,56,615 | 55.64% |
| Institutional Investors | 1 | 19,26,564 | 16.86% |
| Public & Others | 25 | 31,40,980 | 27.49% |
Promoter, institutional & public holding for A.I.Sure Pharmaceutical Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
79 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.